Dr. Sonia Partap, MD
Claim this profileLucille Packard Children's Hospital at Stanford University Medical Center
Studies Brain Tumor
Studies Medulloblastoma
8 reported clinical trials
14 drugs studied
Area of expertise
1Brain Tumor
H3K27M positive
MET positive
Stage III
2Medulloblastoma
MET positive
Affiliated Hospitals
Clinical Trials Sonia Partap, MD is currently running
Savolitinib
for Brain Tumors
This phase I trial studies the side effects and best dose of volitinib in treating patients with primary central nervous system (CNS) tumors that have come back (recurrent) or does not respond to treatment (refractory). Volitinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Recruiting1 award Phase 1
Pembrolizumab
for Pediatric Brain Cancer
This trial studies the safety and effectiveness of pembrolizumab in younger patients with aggressive or treatment-resistant brain tumors. Pembrolizumab is an immunotherapy drug that helps the immune system attack cancer by blocking a protein that stops immune cells from working effectively. Pembrolizumab has been used in various cancers, showing effective antitumor activity and is approved by the FDA for multiple uses.
Recruiting1 award Phase 124 criteria
More about Sonia Partap, MD
Clinical Trial Related4 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Sonia Partap, MD has experience with
- Cyclophosphamide
- Vismodegib
- Cisplatin
- Vincristine
- Craniospinal Irradiation With Boost To The Primary Tumor Site
- Alisertib
Breakdown of trials Sonia Partap, MD has run
Brain Tumor
Medulloblastoma
Diffuse Intrinsic Pontine Glioma
Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sonia Partap, MD specialize in?
Sonia Partap, MD focuses on Brain Tumor and Medulloblastoma. In particular, much of their work with Brain Tumor has involved H3K27M positive patients, or patients who are MET positive.
Is Sonia Partap, MD currently recruiting for clinical trials?
Yes, Sonia Partap, MD is currently recruiting for 3 clinical trials in Palo Alto California. If you're interested in participating, you should apply.
Are there any treatments that Sonia Partap, MD has studied deeply?
Yes, Sonia Partap, MD has studied treatments such as Cyclophosphamide, Vismodegib, Cisplatin.
What is the best way to schedule an appointment with Sonia Partap, MD?
Apply for one of the trials that Sonia Partap, MD is conducting.
What is the office address of Sonia Partap, MD?
The office of Sonia Partap, MD is located at: Lucille Packard Children's Hospital at Stanford University Medical Center, Palo Alto, California 94304 United States. This is the address for their practice at the Lucille Packard Children's Hospital at Stanford University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.